This is a real-life, observational, single-center cohort study to describe the efficacy of prophylactic treatment in patients after failure of at least 2 prophylactic treatments. Patients included in the study will be followed up in consultations or day hospitals according to their usual care, and will be asked to complete the MIgraine Disability Assessment (MIDAS), Headache Impact Test short-form (HIT-6), Patient Global Impression of Change (PGIC), Hospital Anxiety and Depression (HAD) scale and Work and Personal Activities Impairment (WPAI) questionnaires at each visit. Data describing their care will be extracted from computerized patient records.
Study Type
OBSERVATIONAL
Enrollment
127
Real-life, observational, single-center cohort study to describe the efficacy of prophylactic treatment in patients after failure of at least 2 prophylactic treatments. Patients included in the study will be followed up in consultations or day hospitals according to their usual care, and will be asked to complete the MIDAS, HIT-6, PGIC, HAD and WPAI questionnaires at each visit. Data describing their care will be extracted from computerized patient records.
CHR Metz-Thionville/Hopital de Mercy
Metz, France
Headache Impact Test in patients with migraine at 12 months
Using HIT-6 (Headache Impact Test short-form) questionnaire which addresses six main domains affected by headaches, including pain, social functioning, role functioning, cognitive functioning, vitality and psychological stress. This survey is extremely useful for screening and monitoring how headaches affect patients in their day-to-day lives over time. Each item is answered on a 5-point Likert scale (6 = never, 8 = rarely, 10 = sometimes, 11 = very often, 13 = always). The scoring of the HIT-6 was derived to approximate the total score obtained from a larger battery of items, using results from item response theory (IRT) \[10\]. The final score is obtained from simple summation of the six items.
Time frame: 12 months after prophylactic treatments
Headache-related disability in patients with migraine at 12 months
MIDAS scale (Migraine Disability Assessment) measures headache-related disability and improve doctor-patient communication about the functional consequences of migraine. The questionnaire was based on five disability questions that focus on lost time in three domains: schoolwork or work for pay; household work or chores; and family, social, and leisure activities. This instrument is scored as follows: 5 to 10 indicates little or no disability, 10 to 20 indicates moderate disability, and higher than 20 denotes severe disability.
Time frame: 12 months after prophylactic treatments
Anxiety and Depression state evaluation in patients with migraine at 12 months
Using Hospital Anxiety and Depression Scale (HADS) : is a 14-item measure designed to assess anxiety and depression symptoms in medical patients, with emphasis on reducing the impact of physical illness on the total score. The depression items tend to focus on the anhedonic symptoms of depression. Items are rated on a 4-point severity scale. The HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Scores of greater than or equal to 11 on either scale indicate a definitive case.
Time frame: 12 months after prophylactic treatments
Migraine occurence in patients with migraine at 12 months
Number of migraine days
Time frame: 12 months after prophylactic treatments
Crisis treatments in patients with migraine at 12 months
Number of crisis treatments taken
Time frame: 12 months after prophylactic treatments
Patient Global Impression of Change in patients with migraine at 12 months
Using Patient Global Impression of Change (PGIC) score: a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse."
Time frame: 12 months after prophylactic treatments
Work and Personal Activities Impairment in patients with migraine at 12 months
Using Work and Personal Activities Impairment (WPAI) score : a well validated instrument to measure impairments in work and activities. WPAI scores are based on 1-item (presenteeism, activitity impairment), 2-items (absenteeism) and multiple items (overall work productivity).
Time frame: 12 months after prophylactic treatments
Most Bothersome Symptom in patients with migraine at 12 months
Most Bothersome Symptom (MBS)
Time frame: 12 months after prophylactic treatments
Days off work at 12 months
Number of days off work
Time frame: 12 months after prophylactic treatments
Emergency room visits at 12 months
Number of emergency room visits
Time frame: 12 months after prophylactic treatments
Type of prophylactic treatment used at 12 months
Type of prophylactic treatment
Time frame: 12 months after prophylactic treatments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.